7 completed, 2 unknown, 1 not yet recruiting. 10 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 10 | Completed 7, Unknown 2, Not yet recruiting 1 |
Follow Neoplasms, Basal Cell: new trials by email Literature Review of Neoplasms, Basal Cell trials Research Report on Neoplasms, Basal Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Dysport on PMFF Donor Scar Abobotulinumtoxin-A, Control- Saline injection - Skin Cancer Excision Site, Basal Cell Carcinoma | Phase 4 | Not yet recruiting | Vanderbilt University Medical Center | 50 | 2026-09-14 | 2026-08-26 |
| Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China Sonidegib Phosphate Capsules - Carcinoma, Basal Cell (BCC) | Phase 4 | Completed | Jemincare | 160 | 2023-06-21 | 2025-09-24 |
| Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1 Treatment with vismodegib - Metastatic Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma | Phase 4 | Completed | University Hospital, Bordeaux | 27 | 2018-09-03 | 2026-05-19 |
| VISmodegib for ORbital and Periocular Basal Cell Carcinoma Vismodegib - Carcinoma, Basal Cell | Phase 4 | Completed | University of Michigan Rogel Cancer Center | 35 | 2015-07-15 | 2021-10-28 |
| Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate Methylaminolevulinate PDT in 2 sessions, Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT - Superficial Basal Cell Carcinoma | Phase 4 | Unknown | Maastricht University Medical Center | 162 | 2013-08-01 | 2014-01-31 |
| CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial 5-fluorouracil, Placebo, vehicle control - Carcinoma, Basal Cell, Carcinoma, Squamous Cell | Phase 4 | Completed | VA Office of Research and Development | 954 | 2009-06-26 | 2021-06-11 |
| Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma Imiquimod 5% cream - Carcinoma, Basal Cell | Phase 4 | Unknown | University of Sao Paulo | 20 | 2008-12-01 | 2012-06-13 |
| Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC) Imiquimod and Interferon alpha - Basal Cell Carcinoma | Phase 4 | Completed | The University of Texas Health Science Center, Houston | 49 | 2007-12-01 | 2013-01-25 |
| Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage imiquimod - Basal Cell Carcinoma | Phase 4 | Completed | Wake Forest University | 15 | 2005-03-01 | 2023-08-22 |
| Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma Imiquimod - Carcinoma, Basal Cell | Phase 4 | Completed | University Hospital Tuebingen | 100 | 2002-01-01 | 2011-09-01 |
Carcinoma, Basal Cell (10) · Carcinoma (2) · Carcinoma, Squamous Cell (2) · Skin Diseases (2) · Connective Tissue Diseases (1) · Facies (1) · Melanoma (1) · Neoplasms (1) · Neoplasms by Site (1) · Neoplasms, Squamous Cell (1) · Skin Neoplasms (1)
Neoplasms by Histologic Type (10) · Neoplasms, Glandular and Epithelial (10) · Neoplasms (9) · Carcinoma (8) · Skin and Connective Tissue Diseases (3) · Disease Attributes (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Squamous Cell (1) · Neuroectodermal Tumors (1) · Neuroendocrine Tumors (1) · Nevi and Melanomas (1) · Pathologic Processes (1)
Imiquimod (4) · HhAntag691 (2) · Botulinum Toxins, Type A (1) · Fluorouracil (1) · Immunologic Factors (1) · Interferon-alpha (1) · Therapeutics (1) · methyl 5-aminolevulinate (1)
Jemincare (1) · Maastricht University Medical Center (1) · The University of Texas Health Science Center, Houston (1) · University Hospital Tuebingen (1) · University Hospital, Bordeaux (1) · University of Michigan Rogel Cancer Center (1) · University of Sao Paulo (1) · VA Office of Research and Development (1) · Vanderbilt University Medical Center (1) · Wake Forest University (1)
United States (5) · Brazil (1) · China (1) · France (1) · Germany (1) · Netherlands (1)
Cagri Besirli, M.D., Ph.D. (1) · Claus Garbe, MD (1) · Hang Li (1) · Martin A. Weinstock, MD (1) · Phillip M Williford, MD (1) · Shiayin F Yang, MD (1) · Stephen B Tucker, M.D. (1)
PMID 25885553, PMID 27054919, PMID 27207349, PMID 27465252, PMID 27543222, PMID 28088997, PMID 28500658, PMID 28532759, PMID 28621489, PMID 28877312, PMID 29241779, PMID 29299592, PMID 30508548, PMID 30896781, PMID 31647464, PMID 32880186, PMID 33047438, PMID 33988881, PMID 36455049